Compare Koa Shoji Holdings Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 36,855 Million (Small Cap)
10.00
NA
0.00%
-0.37
12.45%
1.25
Revenue and Profits:
Net Sales:
5,680 Million
(Quarterly Results - Mar 2026)
Net Profit:
966 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.58%
0%
0.58%
6 Months
8.55%
0%
8.55%
1 Year
26.35%
0%
26.35%
2 Years
2.86%
0%
2.86%
3 Years
19.86%
0%
19.86%
4 Years
2.62%
0%
2.62%
5 Years
6.94%
0%
6.94%
Koa Shoji Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.55%
EBIT Growth (5y)
12.61%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.81
Tax Ratio
30.14%
Dividend Payout Ratio
18.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.87%
ROE (avg)
13.11%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.22
EV to EBIT
4.61
EV to EBITDA
4.11
EV to Capital Employed
1.35
EV to Sales
1.06
PEG Ratio
1.36
Dividend Yield
NA
ROCE (Latest)
29.22%
ROE (Latest)
12.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
5,679.60
5,361.20
5.94%
Operating Profit (PBDIT) excl Other Income
1,411.50
1,492.10
-5.40%
Interest
6.00
4.30
39.53%
Exceptional Items
0.00
0.00
Consolidate Net Profit
966.40
910.40
6.15%
Operating Profit Margin (Excl OI)
248.50%
245.90%
0.26%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 5.94% vs -0.53% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 6.15% vs 30.24% in Mar 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
23,269.20
22,134.10
5.13%
Operating Profit (PBDIT) excl Other Income
6,046.90
5,108.40
18.37%
Interest
15.10
7.50
101.33%
Exceptional Items
-5.80
26.50
-121.89%
Consolidate Net Profit
3,638.00
2,946.30
23.48%
Operating Profit Margin (Excl OI)
230.10%
198.00%
3.21%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 5.13% vs 0.37% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 23.48% vs 9.64% in Jun 2024
About Koa Shoji Holdings Co., Ltd. 
Koa Shoji Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






